As of 4/10/2026, 11:47:22 AM
Market Cap
18.60B
P/E Ratio (TTM)
17.85
Free Float
-
Volume (30D Avg)
1.20M
1Y Change
-16.48%
Shares Outstanding
228.46M
| Period | Revenue | Profit After Tax | EPS |
|---|---|---|---|
| 2025 | 13.15M | 892,039 | 3.9 |
| 2024 | 12.41M | 833,464 | 3.65 |
| 2023 | 12.40M | 657,984 | 2.88 |
| 2022 | 9.78M | 635,884 | 2.88 |
| Ex-Date | Amount | Yield (%) |
|---|---|---|
| Oct 17, 2025 | Rs. 3.50 | - |
| Oct 17, 2024 | Rs. 3.25 | 7.32% |
| Oct 18, 2023 | Rs. 2.50 | 9.90% |
| Oct 18, 2021 | Rs. 1.50 | 3.81% |
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur
Aslam Malik & Co. Chartered Accountants
F.D Registrar Services (Pvt.) Ltd.
June
Chief Executive Officer
Rizwan Ahmad
Chairperson
Nadeem Amjad
Company Secretary
Muhammad Rasheed Alam
Board of Directors
